A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera.
Roper KJ. et al, (2023), Scientific reports, 13
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.
Shah N. et al, (2023), Artificial organs
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H. et al, (2023), Genome biology, 24
Strategizing Across Organizations
Ramirez R. et al, (2023), MIT SLOAN MANAGEMENT REVIEW, 64, 62 - 65
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients
Gonçalves BP. et al, (2022), eLife, 11
Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number
Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Munblit D. et al, (2022), The Lancet. Respiratory medicine, 10, 715 - 724
Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).
Pazukhina E. et al, (2022), BMC medicine, 20
Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol
Knight SR. et al, (2022), Thorax, 77, 606 - 615
What comes next in the COVID-19 pandemic?
Fisher D. et al, (2022), Lancet (London, England), 399, 1691 - 1692
Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study.
Millar JE. et al, (2022), Scientific reports, 12
Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study.
Närhi F. et al, (2022), The Lancet. Digital health, 4, e220 - e234
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21